VANCOUVER, Canada, Oct. 14 /PRNewswire-FirstCall/ -- ProtoKinetix (OTC Bulletin Board: PKTX), a biotech company focused on the research, development and commercialization of patented anti-aging glycopeptides (AAGPs(TM)), announced today that it has partnered with OTC Financial Network (OTCFN), a division of National Financial Communications Corp. (NFC), to direct a comprehensive shareholder awareness campaign.
"ProtoKinetix' AAGP(TM) platform technology is ideal for a number of applications in the skin care/cosmetics, cellular therapy, blood preservation and pharmaceutical industries," said Geoffrey Eiten, president of NFC. "Last month, ProtoKinetix entered into its first licensing agreement to provide AAGP(TM) as the primary active ingredient in an anti-inflammatory cream for the sports injury market. This contract is one of several in the pipeline that position ProtoKinetix on a path to commercial success. We look forward to introducing the Company and its world-class management team to the financial community."
"We've selected to partner with OTCFN to increase our market awareness and widen our shareholder base," said Ross L. Senior, President and CEO of ProtoKinetix Inc. "We are excited to be working with a financial communications firm that has a well respected track record. We believe we can effectively enhance shareholder value by partnering with companies that offer the technical, marketing and distribution expertise to bring AAGP(TM) applications to market."
About OTC Financial Network
Since 1992, OTC Financial Network (OTCFN) has carved its niche as the nation's leading small/micro-cap investor relations and financial communications firm. OTCFN is a division of National Financial Communications Corp. (http://www.nationalfc.com) based in Needham, MA. For information, visit http://www.otcfn.com.
OTC Financial Networ
Copyright©2008 PR Newswire.
All rights reserved